These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26582203)

  • 1. A Single Glycan at the 99-Loop of Human Kallikrein-related Peptidase 2 Regulates Activation and Enzymatic Activity.
    Guo S; Skala W; Magdolen V; Briza P; Biniossek ML; Schilling O; Kellermann J; Brandstetter H; Goettig P
    J Biol Chem; 2016 Jan; 291(2):593-604. PubMed ID: 26582203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function analyses of human kallikrein-related peptidase 2 establish the 99-loop as master regulator of activity.
    Skala W; Utzschneider DT; Magdolen V; Debela M; Guo S; Craik CS; Brandstetter H; Goettig P
    J Biol Chem; 2014 Dec; 289(49):34267-83. PubMed ID: 25326387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and activity of glycosylated KLKs 3, 4 and 11.
    Guo S; Briza P; Magdolen V; Brandstetter H; Goettig P
    Biol Chem; 2018 Sep; 399(9):1009-1022. PubMed ID: 29975661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein.
    Chen VC; Chao L; Chao J
    J Biol Chem; 2000 Dec; 275(49):38457-66. PubMed ID: 10993887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of IGFBP-3 fragments generated by KLK2 and prevention of fragmentation by KLK2-inhibiting peptides.
    Hekim C; Riipi T; Weisell J; Närvänen A; Koistinen R; Stenman UH; Koistinen H
    Biol Chem; 2010 Apr; 391(4):475-9. PubMed ID: 20180640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of peptides specifically modulating the activity of KLK2 and KLK3.
    Koistinen H; Närvänen A; Pakkala M; Hekim C; Mattsson JM; Zhu L; Laakkonen P; Stenman UH
    Biol Chem; 2008 Jun; 389(6):633-42. PubMed ID: 18627344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors.
    Pakkala M; Hekim C; Soininen P; Leinonen J; Koistinen H; Weisell J; Stenman UH; Vepsäläinen J; Närvänen A
    J Pept Sci; 2007 May; 13(5):348-53. PubMed ID: 17436344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade.
    Eissa A; Amodeo V; Smith CR; Diamandis EP
    J Biol Chem; 2011 Jan; 286(1):687-706. PubMed ID: 20940292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging interest in the kallikrein gene family for understanding and diagnosing cancer.
    Sotiropoulou G; Rogakos V; Tsetsenis T; Pampalakis G; Zafiropoulos N; Simillides G; Yiotakis A; Diamandis EP
    Oncol Res; 2003; 13(6-10):381-91. PubMed ID: 12725528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweetened kallikrein-related peptidases (KLKs): glycan trees as potential regulators of activation and activity.
    Guo S; Skala W; Magdolen V; Brandstetter H; Goettig P
    Biol Chem; 2014 Sep; 395(9):959-76. PubMed ID: 25153382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade. Possible function in seminal plasma and skin.
    Emami N; Diamandis EP
    J Biol Chem; 2008 Feb; 283(6):3031-3041. PubMed ID: 18056261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
    Williams SA; Xu Y; De Marzo AM; Isaacs JT; Denmeade SR
    Prostate; 2010 May; 70(7):788-96. PubMed ID: 20058238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.
    Thorek DL; Evans MJ; Carlsson SV; Ulmert D; Lilja H
    Thromb Haemost; 2013 Sep; 110(3):484-92. PubMed ID: 23903407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity determinants of rat tissue kallikrein probed by site-directed mutagenesis.
    Wang J; Chao J; Chao L
    Protein Eng; 1992 Sep; 5(6):569-75. PubMed ID: 1438168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences.
    Debela M; Magdolen V; Schechter N; Valachova M; Lottspeich F; Craik CS; Choe Y; Bode W; Goettig P
    J Biol Chem; 2006 Sep; 281(35):25678-88. PubMed ID: 16740631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I; Dowler T; Paulsen H
    Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Glycosylation on the Enzymatic Activity and Mechanisms of Proteases.
    Goettig P
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth-and-death of KLK3 and KLK2 in primates: evolution driven by reproductive biology.
    Marques PI; Bernardino R; Fernandes T; ; Green ED; Hurle B; Quesada V; Seixas S
    Genome Biol Evol; 2012; 4(12):1331-8. PubMed ID: 23204305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.